Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI)
暂无分享，去创建一个
P. Mazza | V. Pavone | P. Guglielmelli | F. Passamonti | D. Cilloni | M. Breccia | C. Selleri | G. Palumbo | M. Santoro | S. Impera | D. Pastore | F. Palandri | F. Mendicino | M. Morelli | P. Coco | D. Valsecchi